Contact
Please use this form to send email to PR contact of this press release:
Sanofi and Regeneron Announce Kevzara® (sarilumab) Biologics License Application Resubmission Accepted for Review by US FDA
TO:
Please use this form to send email to PR contact of this press release:
Sanofi and Regeneron Announce Kevzara® (sarilumab) Biologics License Application Resubmission Accepted for Review by US FDA
TO: